David Prieto1, Pedro Correia1, Manuel Baptista1, Manuel J Antunes2. 1. Center of Cardiothoracic Surgery, University Hospital and Medical School, Coimbra, Portugal. 2. Center of Cardiothoracic Surgery, University Hospital and Medical School, Coimbra, Portugal antunes.cct.huc@sapo.pt.
Abstract
OBJECTIVES: There has been a progressive expansion of heart donor selection criteria, including higher age limit. We analysed the impact of using hearts from older age donors (>50 years). METHODS: Between November 2003 and December 2012, 228 heart transplantations were performed. Children and patients requiring ventricular assistance prior to transplantation were excluded. Recipients from 26 donors aged ≥ 50 years (Group A) were compared with those of 136 donors <40 years (Group B). Patient and donor criteria were identical in both groups. RESULTS: Group A recipients were older than those in Group B (59 ± 11 vs 53 ± 11; P < 0.01), and tended to have more ischaemic cardiomyopathy (50 vs 35%; P = 0.16), be in intensive care (31 vs 27%; P = 0.65) and have longer waiting time (56 ± 49 vs 41 ± 47 days; P = 0.15). There were also significant differences in ischaemic time (65 ± 27 vs 93 ± 35 min; P < 0.01). Thirty-day mortality was similar (3.8 vs 3.7%; P = 0.97). Follow-up was 55 ± 32 months. Actuarial survival at 1, 3 and 5 years was 84 ± 7% for Group A and 90 ± 3, 86 ± 3 and 81 ± 4%, respectively, for Group B (P = 0.85). There were no survival differences between patients younger and older than 60 years, but there was a tendency for decreased survival free from cardiac allograft vasculopathy (CAV) in Group A compared to Group B (at 8 years 65 ± 18 vs 78 ± 7%; P = 0.06). CONCLUSIONS: Parameters of exclusion of donor hearts can and must be adjusted, since the use of selected marginal donors associated with short ischaemic times appears to have no negative impact on morbidity and mortality, more importantly when compared with mortality on the waiting list.
OBJECTIVES: There has been a progressive expansion of heart donor selection criteria, including higher age limit. We analysed the impact of using hearts from older age donors (>50 years). METHODS: Between November 2003 and December 2012, 228 heart transplantations were performed. Children and patients requiring ventricular assistance prior to transplantation were excluded. Recipients from 26 donors aged ≥ 50 years (Group A) were compared with those of 136 donors <40 years (Group B). Patient and donor criteria were identical in both groups. RESULTS: Group A recipients were older than those in Group B (59 ± 11 vs 53 ± 11; P < 0.01), and tended to have more ischaemic cardiomyopathy (50 vs 35%; P = 0.16), be in intensive care (31 vs 27%; P = 0.65) and have longer waiting time (56 ± 49 vs 41 ± 47 days; P = 0.15). There were also significant differences in ischaemic time (65 ± 27 vs 93 ± 35 min; P < 0.01). Thirty-day mortality was similar (3.8 vs 3.7%; P = 0.97). Follow-up was 55 ± 32 months. Actuarial survival at 1, 3 and 5 years was 84 ± 7% for Group A and 90 ± 3, 86 ± 3 and 81 ± 4%, respectively, for Group B (P = 0.85). There were no survival differences between patients younger and older than 60 years, but there was a tendency for decreased survival free from cardiac allograft vasculopathy (CAV) in Group A compared to Group B (at 8 years 65 ± 18 vs 78 ± 7%; P = 0.06). CONCLUSIONS: Parameters of exclusion of donor hearts can and must be adjusted, since the use of selected marginal donors associated with short ischaemic times appears to have no negative impact on morbidity and mortality, more importantly when compared with mortality on the waiting list.
Authors: Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala Journal: Rev Bras Ter Intensiva Date: 2016-09
Authors: David M Harmon; Kristen M Tecson; Aayla K Jamil; Joost Felius; Gonzalo V Gonzalez-Stawinski; Susan M Joseph; Shelley A Hall Journal: Proc (Bayl Univ Med Cent) Date: 2019-03-28
Authors: Oliver K Jawitz; Vignesh Raman; Jacob Klapper; Matthew Hartwig; Chetan B Patel; Carmelo Milano Journal: Transpl Int Date: 2019-08-08 Impact factor: 3.782
Authors: R A Sorabella; L Guglielmetti; A Kantor; E Castillero; H Takayama; P C Schulze; D Mancini; Y Naka; I George Journal: Transplant Proc Date: 2015-12 Impact factor: 1.066
Authors: Darae Kim; Jin Oh Choi; Jaewon Oh; Hyun Jai Cho; Sung Ho Jung; Hae Young Lee; Seok Min Kang; Jae Joong Kim; Eun Seok Jeon Journal: Korean Circ J Date: 2019-03-20 Impact factor: 3.243
Authors: Katarzyna Zielińska; Leszek Kukulski; Marta Wróbel; Piotr Przybyłowski; Dominika Rokicka; Krzysztof Strojek Journal: Ann Transplant Date: 2022-02-15 Impact factor: 1.530